查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1726373

全球甲狀腺癌診斷市場：市場規模、佔有率、趨勢分析（按癌症類型、技術、最終用途和地區）、細分市場預測（2025-2030 年）

Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report By Cancer Type (Papillary Carcinoma, Follicular Carcinoma), By Technique (Imaging, Biopsy, Blood Test), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

甲狀腺癌診斷市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球甲狀腺癌診斷市場預計到2030年將達到41.3億美元，預測期內的複合年成長率為5.3%。

該市場的成長歸因於疾病盛行率的增加和新型診斷產品的出現。癌症是世界各地的罕見疾病，但由於診斷工具的敏感性和準確性不斷提高，其發生率正在上升。甲狀腺癌是由於甲狀腺細胞分裂異常而引起的。由於甲狀腺激素調節多種功能，包括體重、體溫、心率和血壓，任何結構或功能異常都可能影響上述部分或全部因素。

意識的提高和公共衛生舉措正在鼓勵更多的人，特別是高風險族群，接受篩檢。再加上醫療基礎設施的不斷擴大和全球醫療支出的不斷增加，這將推動人們獲得先進的診斷服務。監管機構的支持和正在進行的研究努力正在推動液態切片和人工智慧影像分析等創新診斷解決方案的採用。

近年來，隨著生物標記的引入和改進的診斷方法的推出，市場發生了模式轉移。然而，疾病進展和復發率仍然很高，尤其是在老年患者中。強烈的未滿足需求代表著開發突破性的First-in-Class診斷方法的重要機會。

甲狀腺癌診斷市場報告重點

  • 2024 年，乳頭狀癌在癌症類型細分市場中佔據首位，收入為 80.0%。這是由於公眾意識的提高、篩檢舉措的擴大以及影像和分子診斷技術的重大進步，所有這些都使得人們能夠更早、更準確地發現病例。
  • 由於女性脆弱性增加、對快速診斷的重視以及診斷技術的不斷進步，預計預測期內濾泡癌診斷的複合年成長率為 5.6%。
  • 診斷影像技術將在 2024 年佔據最大的收入佔有率，達到 36.9%，這得益於影像解析度的提高以及人工智慧對腫瘤進行精確定位和監測的結合。
  • 由於生物標記分析和次世代定序的進步，提高了診斷準確性並實現了個人化治療，預計切片檢查技術在預測期內將以顯著的複合年成長率成長。
  • 2024 年，醫院實驗室將佔據最大的收入佔有率。預計 2025 年至 2030 年間研究機構的複合年成長率將達到 6.4%。
  • 2024 年，北美將佔據全球甲狀腺癌診斷市場的最大收入佔有率，這主要歸功於其先進的醫療基礎設施、持續的宣傳宣傳活動以及創新診斷解決方案的獲取。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 甲狀腺癌診斷市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 甲狀腺癌診斷市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析

第4章全球甲狀腺癌診斷市場：按癌症類型分類的業務分析

  • 癌症類型儀表板
  • 甲狀腺癌診斷市場：癌症類型的波動分析
  • 全球甲狀腺癌診斷市場規模及趨勢分析（依癌症類型，2018-2030）
  • 乳頭狀癌
  • 濾泡性癌
  • 其他

第5章全球甲狀腺癌診斷市場：按技術分類的業務分析

  • 技術儀表板
  • 甲狀腺癌診斷市場：技術差異分析
  • 全球甲狀腺癌診斷市場規模及趨勢分析（依技術分類）（2018-2030）
  • 血液檢查
  • 影像學診斷
  • 切片檢查
  • 其他

6. 全球甲狀腺癌診斷市場：按最終用途分類的業務分析

  • 按最終用途分類的儀表板
  • 甲狀腺癌診斷市場：依最終用途進行的變化分析
  • 2018-2030年全球甲狀腺癌診斷市場規模及趨勢分析（依最終用途）
  • 醫院檢查室
  • 癌症診斷中心
  • 研究所
  • 其他

第7章全球甲狀腺癌診斷市場：按地區估計和趨勢分析

  • 市場儀表板：按地區
  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 甲狀腺癌診斷市場：各地區要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要企業熱力圖分析（2024年）
  • 公司簡介
    • Abbott
    • F.Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific, Inc.
    • Siemens Healthcare GmbH
    • Bio-Rad Laboratories, Inc.
    • GE HealthCare
    • Hologic, Inc.
    • Koninklijke Philips NV
    • Toshiba Corporation
    • Agilent Technologies, Inc.
    • Illumina, Inc.
Product Code: GVR-4-68038-615-8

Thyroid Cancer Diagnostics Market Growth & Trends:

The global thyroid cancer diagnostics market is anticipated to reach USD 4.13 billion by 2030 and is anticipated to expand at a CAGR of 5.3% over the forecast period, according to a new report by Grand View Research, Inc. The growth of the market is attributed to increasing disease prevalence and the emergence of novel diagnostic products. Although cancer is uncommon worldwide, the incidence rate is on the rise-driven by more sensitive and precise tools to diagnose the disease. It develops as a result of abnormal cell division in the thyroid gland. Since the glandular hormones regulate several functions, such as weight, body temperature, heart rate, and blood pressure, structural or functional anomalies are likely to affect several or all of the aforementioned factors.

Growing awareness and public health initiatives encourage more individuals, especially those at higher risk, to seek screening. This, combined with expanding healthcare infrastructure and increased healthcare spending worldwide, facilitates greater access to advanced diagnostic services. Regulatory support and ongoing research efforts are fostering the introduction of innovative diagnostic solutions, including liquid biopsies and artificial intelligence-driven imaging analysis.

The market has undergone a paradigm shift over the last few years, driven by the introduction of biomarkers and the launch of improved diagnostic products. However, disease progression and recurrence remain high, especially among older patients. Strong unmet needs present a key opportunity to develop breakthrough, first-in-class diagnostics of the disease.

Thyroid Cancer Diagnostics Market Report Highlights:

  • Papillary carcinoma led the cancer type segment with the largest revenue share of 80.0% in 2024. This is attributed to heightened public awareness, the expansion of screening initiatives, and significant progress in imaging and molecular diagnostic methods, all of which have made it possible to identify cases earlier and with greater accuracy.
  • Follicular carcinoma diagnostics is expected to grow at a CAGR of 5.6% over the forecast period, owing to an increased vulnerability among women, a stronger emphasis on prompt diagnosis, and ongoing advancements in diagnostic technologies.
  • Imaging technique held the largest revenue share, 36.9%, in 2024, driven by the incorporation of enhanced imaging resolution and artificial intelligence for precise tumor localization and monitoring.
  • Biopsy technique is expected to grow at a significant CAGR over the forecast period, owing to advances in biomarker analysis and next-generation sequencing, which have improved diagnostic accuracy and supported individualized care.
  • Hospital laboratories accounted for the largest revenue share in 2024. Research institutes are expected to grow at a CAGR of 6.4% from 2025 to 2030.
  • North America dominated the global thyroid cancer diagnostics market with the largest revenue share in 2024, primarily driven by the presence of advanced healthcare infrastructure, ongoing awareness campaigns, and access to innovative diagnostic solutions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Cancer Type
    • 1.2.2. Technique
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Cancer Type Outlook
    • 2.2.2. Technique Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Thyroid Cancer Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Thyroid Cancer Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Thyroid Cancer Diagnostics Market: Cancer Type Business Analysis

  • 4.1. Cancer Type Segment Dashboard
  • 4.2. Thyroid Cancer Diagnostics Market: Cancer Type Movement Analysis
  • 4.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By Cancer Type, 2018 to 2030 (USD Million)
  • 4.4. Papillary carcinoma
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Follicular carcinoma
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Thyroid Cancer Diagnostics Market: Technique Business Analysis

  • 5.1. Technique Segment Dashboard
  • 5.2. Thyroid Cancer Diagnostics Market: Technique Movement Analysis
  • 5.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By Technique, 2018 to 2030 (USD Million)
  • 5.4. Blood Test
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Imaging
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Biopsy
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Thyroid Cancer Diagnostics Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Thyroid Cancer Diagnostics Market: End Use Movement Analysis
  • 6.3. Global Thyroid Cancer Diagnostics Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital Laboratories
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Cancer Diagnostic Centers
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Research Institutes
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Thyroid Cancer Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Global Thyroid Cancer Diagnostics Market by Regional: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. F.Hoffmann-La Roche Ltd.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Thermo Fisher Scientific, Inc.
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Siemens Healthcare GmbH
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories, Inc.
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. GE HealthCare
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Hologic, Inc.
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Koninklijke Philips N.V.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Toshiba Corporation
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Agilent Technologies, Inc.
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Illumina, Inc.
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 Global Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 3 Global Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 4 Global Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5 Global Thyroid Cancer Diagnostics Market, By Region, 2018-2030, (USD Million)
  • Table 6 North America Thyroid Cancer Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 8 North America Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 9 North America Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 12 U.S. Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 15 Canada Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 17 Mexico Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 18 Mexico Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Thyroid Cancer Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 22 Europe Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 23 Germany Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 25 Germany Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 UK Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 27 UK Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 28 UK Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29 France Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 30 France Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 31 France Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 33 Italy Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 34 Italy Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 36 Spain Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 37 Spain Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 39 Denmark Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 40 Denmark Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 42 Sweden Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 43 Sweden Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 45 Norway Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 46 Norway Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Thyroid Cancer Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51 China Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 52 China Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 53 China Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 55 Japan Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 56 Japan Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 India Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 58 India Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 59 India Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 61 South Korea Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 62 South Korea Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63 Australia Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 64 Australia Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 65 Australia Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 67 Thailand Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 68 Thailand Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Thyroid Cancer Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 71 Latin America Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 72 Latin America Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 74 Brazil Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 75 Argentina Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 76 Argentina Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 77 Argentina Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 MEA Thyroid Cancer Diagnostics Market, By Region, 2018 - 2030 (USD Million)
  • Table 79 MEA Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 80 MEA Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 81 MEA Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82 South Africa Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 83 South Africa Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 84 South Africa Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 UAE Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 89 UAE Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 90 UAE Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Thyroid Cancer Diagnostics Market, By Cancer Type, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Thyroid Cancer Diagnostics Market, By Technique, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Thyroid Cancer Diagnostics Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Thyroid Cancer Diagnostics Market: Market Outlook
  • Fig. 10 Thyroid Cancer Diagnostics Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Thyroid Cancer Diagnostics Market Driver Impact
  • Fig. 16 Thyroid Cancer Diagnostics Market Restraint Impact
  • Fig. 17 Thyroid Cancer Diagnostics Market Strategic Initiatives Analysis
  • Fig. 18 Thyroid Cancer Diagnostics Market: Cancer Type Movement Analysis
  • Fig. 19 Thyroid Cancer Diagnostics Market: Cancer Type Outlook and Key Takeaways
  • Fig. 20 Papillary Carcinoma Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Follicular Carcinoma Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 23 Thyroid Cancer Diagnostics Market: Technique Movement Analysis
  • Fig. 24 Thyroid Cancer Diagnostics Market: Technique Outlook and Key Takeaways
  • Fig. 25 Blood Test Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Imaging Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Biopsy Market Estimates and Forecast, 2018 - 2030
  • Fig. 28 Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Thyroid Cancer Diagnostics Market: End Use Movement Analysis
  • Fig. 30 Thyroid Cancer Diagnostics Market: End Use Outlook and Key Takeaways
  • Fig. 31 Hospital Laboratories Market Estimates and Forecasts, 2018 - 2030
  • Fig. 32 Cancer Diagnostic Centers Market Estimates and Forecasts, 2018 - 2030
  • Fig. 33 Research Institutes Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Global Thyroid Cancer Diagnostics Market: Regional Movement Analysis
  • Fig. 36 Global Thyroid Cancer Diagnostics Market: Regional Outlook and Key Takeaways
  • Fig. 37 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Kuwait Market Estimates and Forecasts, 2018 - 2030